Fidelity Investments’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Fidelity Investments’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,910,155	Closed	-$6.8M	–	4386
2019 Q1	$6.8M	Sell	3,910,155 -1,089,845	-22%	-$1.51M	﹤0.01%	1986
2018 Q4	$4.2M	Sell	5,000,000 -1,315,800	-21%	-$1.57M	﹤0.01%	2096
2018 Q3	$8.97M	Hold	6,315,800	–	–	﹤0.01%	1961
2018 Q2	$5.21M	Hold	6,315,800	–	–	﹤0.01%	2141
2018 Q1	$8.65M	Hold	6,315,800	–	–	﹤0.01%	1997
2017 Q4	$6.38M	Hold	6,315,800	–	–	﹤0.01%	2099
2017 Q3	$9.6M	Hold	6,315,800	–	–	﹤0.01%	1952
2017 Q2	$11.7M	Hold	6,315,800	–	–	﹤0.01%	1887
2017 Q1	$8.27M	Hold	6,315,800	–	–	﹤0.01%	2037
2016 Q4	$4.41M	Hold	6,315,800	–	–	﹤0.01%	2206
2016 Q3	$7.01M	Hold	6,315,800	–	–	﹤0.01%	2100
2016 Q2	$9.03M	Hold	6,315,800	–	–	﹤0.01%	2016
2016 Q1	$6.26M	Hold	6,315,800	–	–	﹤0.01%	2096
2015 Q4	$20.3M	Hold	6,315,800	–	–	﹤0.01%	1686
2015 Q3	$19.5M	Hold	6,315,800	–	–	﹤0.01%	1665
2015 Q2	$22.2M	Buy	+6,315,800	New	+$26.9M	﹤0.01%	1686

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Fidelity Investments's CVRS Position: Q2 2019 in Review

Fidelity Investments sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2019, closing a stake of 3,910,155 shares — an estimated $6.8M sold.

Fidelity Investments first reported a position in CVRS in Q2 2015 and held it in 16 quarters. The position peaked at $22.2M in Q2 2015. 81 funds tracked by Wall St. Rank hold CVRS as of Q2 2019.

Fidelity Investments reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2019 after selling out during the quarter.
Fidelity Investments sold 3,910,155 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2019, an estimated $6.8M.
Fidelity Investments first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 16 quarters.
Fidelity Investments's CORINDUS VASCULAR ROBOTICS, INC position peaked at $22.2M in Q2 2015.
81 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2019.

Based on Fidelity Investments's 13F filing for Q2 2019, filed 13 Aug 2019.